Defiance ETFs’s Medtronic MDT Stock Holding History

Defiance ETFs’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$405K	Buy	5,118 +864	+20%	+$69.7K	0.01%	294
2026 Q1	$369K	Buy	+4,254	New	+$408K	0.01%	287

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Defiance ETFs's MDT Position: Q2 2026 in Review

Defiance ETFs increased its Medtronic (MDT) stake by 20% in Q2 2026, buying an estimated $69.7K and bringing the position to 5,118 shares worth $405K. The position accounts for 0.01% of the portfolio, ranked #294.

Defiance ETFs first reported a position in MDT in Q1 2026 and has held it in 2 quarters since. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Defiance ETFs held 5,118 shares of Medtronic worth $405K as of Q2 2026.
Defiance ETFs bought 864 Medtronic shares in Q2 2026, an estimated $69.7K.
Medtronic made up 0.01% of Defiance ETFs's portfolio in Q2 2026, its #294 holding.
Defiance ETFs first reported a position in Medtronic in Q1 2026 and has held it in 2 quarters since.
2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Defiance ETFs's 13F filing for Q2 2026, filed 14 Aug 2026.